T1	Participants 69 126	previously treated patients with metastatic breast cancer
T2	Participants 129 292	Three hundred twenty-five women with metastatic adenocarcinoma of the breast who had failed one prior chemotherapeutic regimen for advanced disease were randomized
T3	Participants 390 431	Enrollment was closed on October 31, 1984
